Beaker Health partners with healthcare organizations to organize and measure their content while becoming a learning platform. This content can then be disseminated for new visibility and revenue directly into third parties (e.g. academic institutions) for world-class education, just-in-time learning, and continuous updates.

Manufacturer of protective cases for iPhones and iPads designed for healthcare, education, and retail mobility. The company's cases are impact-resistant and made with disinfectant-ready plastics. They also offer swappable batteries and multi-charging options to extend battery life for long work shifts. The company has experience working with hospitals.

BeCareLink is a digital technology company that harnesses artificial intelligence to supplement, augment, and replace traditional clinical therapy. The company delivers quantifiable neurological assessments to help manage health. BeCareLink provides quantitative data to track progress and share with the chosen healthcare provider. The applications are available on Android and iOS.

Becker's Healthcare offers forward looking business news, analysis and guidance relating to the healthcare industry. Our portfolio includes five industry-leading trade publications: Becker's Hospital Review Becker's ASC Review Becker's Spine Review Becker's Clinical Leadership & Infection Control Becker's Dental Review Want to learn more? Sign up for our free E-newsletters here: https://beckers.dragonforms.com/BCKR_prefsnew&pk=LINKEDIN2020 Check out this video highlighting a company culture we're proud of: vimeo.com/386545828/4d987b8dc9

Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. For more than 75 years, our products have been making a difference in peoples' lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery.

Zeus Capital a dynamic venture fund dedicated to nurturing and empowering early-stage startups, shaping the next generation of disruptive innovators. Our mission is to identify and back exceptional entrepreneurs with bold ideas, providing them with strategic guidance, capital, and resources to transform industries and propel visions into reality. Leveraging our extensive network and vast industry expertise, we foster collaborative partnerships to accelerate growth, drive success, and create lasting impact.

Developer of a secure software-as-a-service collaboration platform designed to create secure data access to support impactful algorithm validation and development. The company's platform supports end-to-end data and algorithm encryption that ensures data security, uses primary data from the source rather than synthetic or de-identified data, eliminates the risk of data exfiltration and interrogation of the algorithm IP from insiders and third parties, and acts as the middleman and matchmaker between data stewards and algorithm developers, helping healthcare organizations in keeping their data secure in their private cloud infrastructure.

BehaVR creates digital therapeutics for behavioral health using Virtual Reality. It focuses on the intersection of behavioral health and chronic disease, building skills of stress resilience, emotional regulation, and self-efficacy, helping people better cope with their conditions, be more adherent to care plans, and improve their overall health.

Founded in 2010, BeiGene is a global biotechnology company that discovers and develops innovative oncology treatments and aims to make their medicines more accessible and affordable to cancer patients worldwide. The company has more than 9,200 colleagues globally and administrative offices on three continents, as well as one of the largest oncology research teams in the world. BeiGene continues to expand its broad in-house internal clinical development capabilities to make its therapies more available for patients around the globe. BeiGene’s innovative BTK inhibitor BRUKINSA® (zanubrutinib) has been approved in more than 65 markets as a treatment for various blood cancers, and the company's other internally developed cornerstone medicine, tislelizumab, is currently under review by regulators in the U.S. and the EU for the treatment of advanced or metastatic esophageal squamous cell carcinoma after prior chemotherapy. The company’s broad and deep pipeline has the potential to address 80 of cancers by incidence. Adjacent to its product portfolio and pipeline, the company also sponsors programs aimed at serving the broader needs of oncology patients, such as a program to raise awareness of mental health resources for people and families affected by cancer.

Bellin Health operates as an integrated health care delivery system. Bellin Health is comprised of Bellin Health hospitals, specialty care clinics, psychiatric centers, fitness centers and professional schools. The Bellin Health system fosters an environment that gives employees many career options and a diverse range of opportunities.